Hyperglycemia and nocturnal systolic blood pressure are associated with left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients

Cardiovascular Diabetology

Volumn 5, Issue , 2006, Pages

  Felício, João S ^a   Pacheco, Juliana T ^a   Ferreira, Sandra R ^b   Plavnik, Frida ^c   Moisés, Valdir A ^c   Kohlmann Jr , Oswaldo ^c   Ribeiro, Artur B ^c   Zenella, Maria T ^c  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GLYCEMIC CONTROL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; DIASTOLE; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; SYSTOLE;

EID: 33749399965     PISSN: 14752840     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-5-19     Document Type: Article

References (43)

1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A: New type of cardiomyopathy associated with diabetic glomeruloesclerosis. Am J Cardiol 1972, 30:595-602.
2. Blumenthal HT, Alex M, Goldenberg S: A study of lesions of the intramural coronary artery branches in diabetes mellitus. Arch Pathol 1960, 70:13-28.
3. Fein FS: Diabetic cardiomyopathy. Diabetes Care 1990, 13:1169-1179.
4. Barbagallo M, Gupta R, Resnick L: Cellular ions in NIDDM: relation of calcium to hyperglycemia and cardiac mass. Diabetes Care 1996, 19:1393-1398.
5. Paulson DJ, Crass MF: Myocardial triacyglycerol fatty acid composition in diabetes mellitus. Life Sci 1980, 27:2237-2243.
6. Uusitupa M, Mustonen J, Airaksinen J: Diabetic heart muscle disease. Ann Med 1990, 22:377-386.
7. Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T: Left ventricular mass in diabetes-hypertension. Arch Int Med 1992, 152:1001-1004.
8. Vicenza S, Menzinger G: Relationship between autonomic neuropahty, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 1994, 17:578-584.
9. Felicio JS, Ferreira SRG, Plavnik FL, Moisés V, Kohlmann O Jr, Ribeiro AB, Zanella MT: Effect of blood glucose on left ventricular mass in patients with hypertension and type 2 diabetes mellitus. Am J Hypertens 2000, 13(11):1149-1154.
10. Joint National Committe on Detection, Evaluation and Treatment of High Blood Pressure: The Fifth Report of The Joint National Committe on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153:154.
11. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979, 28:1039-1057.
12. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantification in M-mode echocardiography measurements. Circulation 1978, 58:1072-1083.
13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
14. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987, 59:956-960.
15. Nishimura RA, Abel MD, Hatle LK, Tajek AL: Assessment of diastolic function of the heart: background and current aplications of Doppler echocardiography. Part II. Clinical studies. Mayo Clin Proc 1989, 64:181-204.
16. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977, 55:613-618.
17. Palmieri V, Bella JN, Arnett DK, Liu JE, Obverman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC, Devereux RB: Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation 2001, 103:102-107.
18. Tenenbaum A, Fisman EZ, Schwammenthal E, Adler Y, Benderly M, Motro M, Shemesh J: Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus. Cardiovasc Diabetol 2003, 23:14.
19. Galderisi M, Anderson KM, Wilson PW, Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991, 68:85-89.
20. Nielsen F, Rossing P, Bang L, Svendsen T, Gall M, Smidt U, Parving H: On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995, 44:783-789.
21. Mulec H, Blohme G, Kullenberg K, Nyberg G, Björck S: Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia 1995, 38:216-220.
22. Rutter MK, McComb JM, Fotster J, Brady S, Marshall SM: Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria. Diabetic Medicine 2000, 17(4):321.
23. Molnar GD, Taylor WF, Longworthy A: On measuring the adequacy of diabetes regulation: comparison of continuously monitored blood glucose patterns with values at selected time points. Diabetologia 1974, 10:139-143.
24. Holman RR, Turner RC: The basal plasma glucose. a simple relevant index of maturity-onset diabetes. Diabetes 1980, 14:279-286.
25. Aleyassine H, Gardiner J, Toules DB, Koch P: Glycosylated haemoglobin in diabetes mellitus: correlation with fasting plasma-glucose, serum lipids and glucosuria. Diabetes Care 1980, 3:508-514.
26. Graf RJ, Holger JB, Porte D: Glycosylated haemoglobin in normal subjects and in subjects with maturity onset diabetes. Evidence for a saturable system in man. Diabetes 1978, 27:834-839.
27. Walinder O, Wibell L, Tuvemo T: Relation between haemoglobin A1 and determination of glucose in diabetes treated with and without insulin. Diabete Metab 1980, 6:251-255.
28. Wettre S, Arnqvist HJ, Von Schenck H: Assessement of glycaemic control in non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 1993, 53:163-170.
29. Andersson DKG, Svãrdsudd K: Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995, 18:1534-1543.
30. Hansen KW, Pedersen MM, Marshal SM, Christiansen JS, Mogensen CE: Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia 1992, 35:1074-1079.
31. Gambardella S, Frontoni S, Spallone V: Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens 1993, 6:97-102.
32. Coutinho M, Gerstein HC, Yang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999, 22:233-240.
33. Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Hoof RV, Amery AK: Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol 1991, 1:723-727.
34. Levy D, Garrison RJ, Savage DD, Kannel WB, Casteli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Eng J Med 1990, 322:1561-1566.
35. Ghali KJ, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS: The prognostic role of left ventricular hypertrophy in patients with and without coronary artery disease. Ann Intern Med 1992, 117:831-836.
36. Fujita. M, Mikuniva A, McKnown DP, McKnown MD, Franklin D: Regional myocardial volume alterations induced by brief repeated coronary oclusions in conscious dogs. J Am Coll Cardiol 1988, 12:1048-1053.
37. Naka M, Hiramatsu Q, Aizawa T, Momose A, Yoshizawa K, Shigematsu S: Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 1992, 123:46-53.
38. Koistinen MJ: Prevalence of asymptomatic myocardial ischuemia in diabetic subjects. Br Med J 1990, 301:92-95.
39. Cruickshank JM, Lewis J, Moore V, Dood C: Reversibility of left ventricular hypertrophy by differing types of antihypertensive teraphy. J Hum Hypertens 1992, 6:85-90.
40. Salmasi AM, Rawlins S, Dancy M: Left ventricular hypertrophy and preclinical impaired glucose tolerance and diabetes mellitus contribute to abnormal left ventricular diastolic function in hypertensive patients. Blood Press Monit 2005, 10(5):231-238.
41. Westo RS, Zarich SW, Jacob RM, Kamalesh M: From Heart disease in diabetes. Joslin's diabetes mellitus - 13th. Philadelphia 1994:836-851.
42. Aepfelbacher FC, Yeon SB, Weinrauch LA, D'Elia J, Burger AJ: Improved glycemic control induces regression of left ventricular mass in patients with type 1 diabetes mellitus. Int J Cardiol 2004, 94:47-51.
43. Cuspidi C, Lonati L, Sampieri L, Michev I, Macca G, Roccanova JI, Salerno M, Fusi V, Leonetti G, Zanchetti A: Prevelence of target organ damager in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control. J Hypertens 2000, 18:803-809.